You are here

Japan

Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan

Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan

Motley Fool

prostate cancer

pancreatic cancer

Flag link:

Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up

Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up

Endpoints

Flag link:

Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis

Astellas, FibroGen get approval in Japan for Evrenzo to treat anaemia of CKD in adult patients not on dialysis

Pharmaceutical Business Review

chronic kidney disease

Flag link:

Game on: Pfizer, BioNTech prepare to put COVID-19 shot distribution plan to the test after interim readout

Game on: Pfizer, BioNTech prepare to put COVID-19 shot distribution plan to the test after interim readout

Fierce Pharma

drug manufacturing

Flag link:

Poxel posts phase 3 diabetes data ahead of approval decision

Poxel posts phase 3 diabetes data ahead of approval decision

Fierce Biotech

clinical trials

Flag link:

Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan

Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan

Motley Fool

Moderna Therapeutics

Flag link:

Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown

Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown

Fierce Pharma

early retirement

Flag link:

FDA gives speedy approval to another Duchenne drug

FDA gives speedy approval to another Duchenne drug

BioPharma Dive

Duchenne Muscular Dystrophy

Flag link:

Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan

Novavax Partners With Takeda to Sell Its Coronavirus Vaccine in Japan

Motley Fool

Flag link:

Pfizer, BioNTech score deal to supply 120M Covid-19 vaccine doses to Japan

Pfizer, BioNTech score deal to supply 120M Covid-19 vaccine doses to Japan

MedCity News

Flag link:

Teva, Takeda offload generics, manufacturing plant to Nichi-Iko in Japanese venture reshuffle

Teva, Takeda offload generics, manufacturing plant to Nichi-Iko in Japanese venture reshuffle

Fierce Pharma

Teva Pharmaceutical

drug manufacturing

Flag link:

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Pharmaforum

Flag link:

GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival

GSK’s kidney disease anemia drug approved in Japan, taking on Astellas’ rival

Pharmaforum

chronic kidney disease

Flag link:

AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful

AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful

Fierce Pharma

University of Oxford

Flag link:

Sosei pens inflammatory and autoimmune disease drug pact with AbbVie

Sosei pens inflammatory and autoimmune disease drug pact with AbbVie

Fierce Biotech

Flag link:

Takeda posts surprise profit a year after Shire mega-merger

Takeda posts surprise profit a year after Shire mega-merger

Pharmaforum

Flag link:

Japan approves Gilead Sciences' remdesivir as COVID-19 drug

Japan approves Gilead Sciences' remdesivir as COVID-19 drug

Reuters

Gilead Sciences

Flag link:

Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report

Gilead's COVID-19 hopeful remdesivir may get swift Japanese approval: report

Fierce Biotech

Gilead Sciences

Flag link:

Esperion strikes Japan deal for 'goldilocks' cholestrol drug, bags $60M cash as pandemic forces virtual US rollout

Esperion strikes Japan deal for 'goldilocks' cholestrol drug, bags $60M cash as pandemic forces virtual US rollout

Endpoints

Flag link:

White House pressures FDA on unproven Japanese drug

White House pressures FDA on unproven Japanese drug

Politico

Flag link:

Pages